Mark Phillip Arrington

Title: The Innovations of Mark Phillip Arrington

Introduction

Mark Phillip Arrington is a notable inventor based in Westwood, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific enzymes related to psychiatric and neurological disorders. His work has the potential to impact the treatment of various mental health conditions.

Latest Patents

Mark Phillip Arrington holds a patent for "Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors." This patent describes the use of certain thienopyrimidine derivatives for inhibiting PDE10 enzymes. These compounds are particularly useful in treating psychiatric or neurological syndromes, such as psychoses, obsessive-compulsive disorder, and Parkinson's disease. The innovation represents a promising avenue for addressing diseases modulated by PDE10 activity. He has 1 patent to his name.

Career Highlights

Arrington is associated with Memory Pharmaceuticals Corporation, where he has been instrumental in advancing research and development in the pharmaceutical sector. His expertise in medicinal chemistry and pharmacology has contributed to the company's mission of creating effective treatments for complex neurological conditions.

Collaborations

Throughout his career, Mark has collaborated with notable colleagues, including Ruiping Liu and Allen T Hopper. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Mark Phillip Arrington's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions to the development of PDE10 inhibitors highlight the importance of research in addressing significant health challenges.